M. Atherton, Outcome measures of efficacy associated with a Web-enabled asthma self-management programme - Findings from a quasi-experiment, DIS MANAG H, 8(4), 2000, pp. 233-242
Objective: To assess the efficacy of a World Wide Web-enabled asthma selfma
nagement intervention on quality-of-life indicators among self-selected par
ticipants with asthma.
Design: A quasi-experimental design was used in which quality-of-life outco
me indicators were derived from the Mini Asthma Quality of Life Questionnai
re (MiniAQLQ); this self-administered instrument includes a global score an
d 4 domain scores (emotional status, environmental triggers, symptoms and a
ctivity restrictions). Baseline and re-measure scores were statistically te
sted for change over a 6-month period of engaged participation.
Intervention: The web-enabled interactive MyAsthma(TM) intervention which b
uilds on patient-centred self-management skills based on education, appropr
iate medication usage and symptom control.
Participants: A national sample of 437 patients with self-reported symptoms
of mild intermittent to severe asthma who registered as participants in My
Asthma(TM) Engaged use of the Internet for building asthma self-management
skills was examined as a construct of participation in the intervention.
Main outcome measures and results: Based on participants' self-reported res
ponses, high volume users of the web-enabled intervention reported improved
quality-of-life scores that were both statistically and clinically signifi
cant.
Participants with a documented number of site visits greater than the group
median (17 or more visits over the 6-month period of observation) were 1.6
times more likely to report an improvement in their global MiniAQLQ score
compared with participants with less than the median number of visits [adju
sted odds ratio (OR) = 1.60, 95% confidence interval (CI) 1.03, 2.48]. A si
milar effect associated with website visit frequency was observed with resp
ect to participants' emotional subscales scores (adjusted OR = 1.76, 95% CI
1.09, 2.85) and activity subscale scores (adjusted OR = 1.64, 95% CI 1.06,
2.55).
Conclusions: Based on pre-/post-test measures derived from a standardised a
nd validated instrument, the web-enabled MyAsthma(TM) self-management progr
amme was associated with a positive change in patient reported scores of qu
ality of life. Although these results are preliminary and not derived from
rigorously controlled clinical trials, the strength of this evidence is not
eworthy nonetheless. We acknowledge that self-selection bias in observation
al studies is a threat to both internal and external validity. Research bas
ed on randomised clinical trials is needed to further document the effects
of web-enabled disease management interventions targeting patients with ast
hma.